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Summary of conclusions and recommendations 
CamBioTec has developed into a successful network of persons, with good 
capabilities to promote biotechnology through support to policy design and 
management and brokering of joint ventures between companies and 
governmental agencies, which has had a significant impact in its short lifetime. It 
has been less successful till now to promote research into the socio-economics of 
biotechnology and in promoting direct applications of biotechnologies. 
2. To continue and improve their role as "biotechnology champions", CamBioTec 
focal points need to institutionalize, that is, broaden their political legitimacy, 
improve their services and generate the funds needed to cover their core costs. 
This means the creation of new organizations, with participation of industiy, 
governmental agencies and research centers, in Chile, Colombia and Mexico, as 
well as closer integration of the Argentinean focal point with the Foro Argentino 
de Biotecnologia. 
3. The feasibility of such an step is high in all countries, if IDRC supports 
CamBioTec during a two year transition period, with guidance and challenge 
funding for some core costs of the focal points. 
4. The network as such also has to formalize, creating a governing instance and 
developing a common workplan. 
5. It is therefore recommended that JDRC approves a second phase of the 
CamBioTec project, with the objectives of institutionalization of the focal points 
where needed, formalization of the network, and use of CamBioTec capabilities 
to develop the socio-economic research and environmental biotechnology 
activities pending from the first phase. 
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Inuction 
CamBioTec is a project, approved by 1DRC in January 1995, to "promote, 
facilitate and support collaborative activities among Latin American and Canadian 
researchers, entrepreneurs and key institutions to expedite the introduction of 
biotechnology-based products and applications in the agrifood and environmental 
management sectors of selected Latin American countries, in critical areas of socio- 
economic and environmental need" (IDRC, 1994). Coordinated by Dr. Jose Luis Solleiro 
of the Technological Innovation Unit of the Engineering Institute (former Centre for 
Technological innovation, CIT) of the National Autonomous University of Mexico 
(UNAM), it includes national coordinating institutions (Focal points) responsible for 
local activities in Canada (BioteCanada), Mexico (Instituto de Ingenieria, UNAM), 
Argentina (Foro Argentino de Biotecnologia), Chile (Conicit-University of Chile), 
Colombia (Fundacion Tecnos) and Cuba (Biotechnology and Genetic Engineering 
Institute), integrated into a network with a common program of activities, with a budget 
of Can$ 1,000,000 financed by IDRC and significant contributions by local institutions. 
After three years of existence, an extensive list of activities have been carried out. 
As originally planned, an external review has been contracted to assess the different 
actions, their impacts and to make recommendations on "the future strategic orientation 
and activities of the network, with attention to the overall goals of the network, key 
clients and services, organizational structure, financing strategy (local and international) 
and cost-recovery mechanisms, and priority actions over the next 6-12 month" (IDRC 
1998). 
To this end the consultant has reviewed the documentation on the project 
provided by IDRC, the Project Coordinator and the Focal Points and has interviewed, 
directly or telephonically, 64 persons in Canada, Mexico, Colombia, Chile and Argentina 
(See Annex 1). Extensive discussions have been held with IDRC staff, the Project 
Coordinator and each of the Coordinators in Mexico, Colombia, Chile and Argentina. 
IDRC decided not to include Cuba in this assessment, given that its Focal Point has been 
inactive. 
A two-day meeting was held in Mexico with IDRC staff, the Project Coordinator 
and the coordinators of the focal points (excluding Cuba) to discuss the conclusions and 
recommendations of the consultant and to devise a strategy for the consolidation of 
CamBioTec. 
Concept and design of CamBioTec 
The general objective of CamBioTec comprised the following four specific 
objectives: I) To implement technology foresight and priority-setting methodologies; 2) 
To strengthen public policy in the field of biotechnology; 3) To promote improved 
management of innovation in biotechnology firms; and 4) To foster Canada-Latin 
America technology partnering arrangements. 
The specific objectives were conceived as sequential phases in a logical order 
leading from the identification of what should be done (priority setting), definition of 
how to do it (policy research), promotion of specific alternatives to do it (partnering) and 
finally, strengthening of capacities to do it ( support in management of biotechnology). 
This conceptual design is based on the idea that, very schematically, 
biotechnology research in Latin America lacks an adequate strategic focus, as it is 
basically academic, disconnected of the productive sector; that- government policies 
promoting biotechnology are basically science policies responding to an academic 
constituency; and that producers and industry to be impacted by biotechnology have yet 
to realize the opportunities and threats posed by it. 
Underlying the proposal are several hypothesis and proposals more or less 
explicitly exposed in the background considerations of the project document, which are 
the following: 
- Biotechnology will have a large and profound impact on all economic sectors 
based on the exploitation of living beings and theirs products. 
- Latin American countries will be affected in an important way, given the 
importance of traditional, biologically based, sectors in their economies. 
- The only way Latin American countries have to face these challenges is to take 
the most advantage of the developments being done in leading countries, that is, 
access intelligently available technologies, given the weakness in local research 
capabilities. 
- Public policies towards this end should encourage the development of some 
science capabilities so to understand, monitor and select the most relevant 
developments, but principally should facilitate the access, i.e. transfer of, to the 
relevant technologies and support the incorporation of biotechnology by industry. 
The diagnostic and strategy proposal for Latin American biotechnology made by 
CamBioTec is basically correct, leading to its focus on policy and 
management issues. This approach stands out among the rest of regional or national 
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initiatives to promote biotechnology in the region, which typically are oriented towards 
research promotion and support. 
On a more specitic level of analysis, there are some problems with the design and 
with some of the chosen strateQies. 
First, the proposal of sequential development of the phases does not correspond to 
about 15 years of different policy, research and industrial initiatives and actions in 
biotechnology in every country, which have produced a certain level of development in 
biotechnology capabilities and uses. This scenario calls for a much more practical and 
flexible approach of strengthening or creating activities tailored to the different situations 
in each country. 
Secondly, the strong emphasis on planning activities and their specific design (i.e. 
concentration on nationaLpriority setting) is based on a conception of the role of central, 
state-led planning of the economy and development typical of the past import- 
substitution period of development polities in Latin America which is out of favor in 
most, if not all, countries of the region. If these exercises are initiated and run out-side of 
the responsible science or industrial policy organizations they are specially problematic. 
A more realistic and effective approach to this planning question would have 
been explicitly acknowledge the limitations of the more dirigistic alternatives, and design 
activities to help develop a basic consensus on the different policy questions related to 
biotechnology development. An effective public policy in the new political and 
economical environment in Latin America has to be based on a shared view of the 
importance and role of biotechnology in the countries. This view is both general for 
biotechnology, but also specific for the different sectors to be impacted by biotechnology. 
Thirdly, the promotion of specific biotechnology applications and uses through 
feasibility studies, as proposed in the project, has clear limits for organizations without 
investment capabilities, such as the focal points. They should not go much further than 
the identification of opportunities, and leave specific feasibility studies to the interested 
parties, such as industries, investors or some governmental organizations, so to reduce 
the risk of waste of resources. 
These problems in the design of the project clearly affected the operation of some 
of its activities. 
Operation 
Summary of activities 
The CamBioTec project has carried out an important number of activities, as 
shown in Annex 2, in the three years it has been operative in Canada and Mexico, two 
and a half in Argentina and Colombia and one year in Chile. 
The activities concentrated in general on the planning objectives and on 
partnering: 
- Argentina developed a priority setting exercise in close cooperation with the 
governmental science policy agency (Secretaria de Ciencia y Tecnica), supported 
the discussion on biosafety issues, did a survey to gather information on 
organizations and companies involved with biotechnology and supported several 
companies interested in partnering with Canada. 
- Given the advanced stage of biotechnology promotion and planning in Canada, 
the Canadian focal point concentrated in partnering activities, both of companies 
and of public organizations interested in linkages with Latin America in the field 
of biosafety and environmental applications of biotechnology. An international 
seminar on socio-economic impacts of biotechnology was held in this country. 
- Chile was included latter than the rest of countries in the project and 
concentrated in policy issues (biosafety) and partnering. The focal point decided 
not to do an priority setting exercise given the unfavorable climate to such 
activities in the country. A biotechnology industry directory was just finished. 
- In the case of Colombia, a priority setting exercise was initiated, which still has 
to conclude, in support ófColciencias, the governmental science policy agency. A 
seminar in the area of intellectual property was organized and partnering 
activities have been carried out. 
- The Mexican focal point combined the general coordination of the project, 
which included the organization of several common activities between the 
participating countries, and the specifically national activities. The project being 
an out-grow of a previous IDRC project with the CIT, it carried out the most 
complete range of activities of all participating countries. It developed a priority 
setting exercise in one of the states of Mexico (Chihuahua), did a serie of 
technology monitoring studies, supported the formulation of a national policy for 
regulating the access to genetic resources as well as in biosafety, up-dated a 
biotechnology directory, contracted three socio-economic impact studies, 
organized seminars on biotechnology management issues and supported several 
partnering initiatives. It also promoted the application of a specific biotechnology, 
the production of a hiopesticide, through a market study, a feasibility study, the 
selection of a interested industry and the negotiation of the financing of this 
venture. 
Very rapidly in the execution of the project it became clear that the sequential 
order of the activities envisioned in its design was not practical, and activities were 
developed depending on the interest and possibilities in each case. Particularly the 
studies on socio-economic impacts of biotechnologies were left for latter stages, and it is 
only very recently that three case studies have been selected to be initiated soon. 
All focal points did activities in planning, support to policy development, 
information and brokering of partnerships. Socio-economic research and promotion of 
the application of specific biotechnologies were only done in Mexico. 
Pertbrmance 
This flexibility in the execution of the project is very evident in the comparison of 
the expected outputs included in the project document with the real outputs three years 
latter, as shown in Table 2. There are significant variations in the results compared to the 
initial vision of the project. They are the consequence of unrealistic expectations, on the 
one hand, and of loose follow-up and control of some activities in other cases. 
In the first case, some of the problems stem from the original design of the 
project. These problems were recognized during its execution leading to changes in the 
workplan. The example of the feasibility studies of specific applications of biotechnology 
in priority areas has already been mentioned. Another similar case is the proposed 
bioindustrial R&D fund, which seems at the least a too advanced or ambitious idea for 
the typical situation of biotechnology or, even more generally, science and technology in 
the region. 
Some of the activities would have benefited from a tighter organization and 
follow-up. Several proceedings of seminars, for example, still haven't been published. 
One of the priority setting exercises is not finished, endangering its impact and 
usefulness, since its client organization is advancing more rapidly and could therefore not 
use its results. 
The events done by CamBioTec have generally being well organized. Selection of 
participants, design of agenda, logistics, media coverage, etc. have been, in the opinion of 
interviewed persons, good. Proceedings are lacking for some of them, and others are 
weak. 
The quality of products of the studies and information activities have being 
uneven. Some of the technology monitoring studies are excellent, but their value and 
impact have been reduced because of their focus on only one country. The directories 
need to improve in relation to their coverage and presentation of data. Data bases on 
different aspects of national biotechnology in each focal point with a common structure, 
which eventually would permit the interchange and sharing of data, are lacking. 
It has to be pointed out that some of the variations are due to new initiatives, that 
is, not envisioned originally, which is considered a very positive variation. For example, 
the project negotiated a new activity with separate funding to strengthen regulatory 
bodies in Argentina and Chile. A CaruBioTec prize to stimulate interest in research on 
socio-economic aspects of biotechnology was created in Mexico. 
Table 2: Performance of CamBioTec 
Expected out-puts Real out-puts 
Priority setting 
3-4 foresight activities 9 monitoring studies 
4 quarterly reports No 
Priority setting exercises (3?) 2 
Report of exercises 1 
Policy research/Public policy 
Background studies l(?) 
9 bimonthly policy briefs No 
Consensus building exercises 7 (seminars) 
Institutional strengthening (new) 
Socio-economic impacts 
2 international meetings 1 
1-2 pilot studies 3 initiated 
CamBiotec prize in Mexico (new) 
Partnering 
Brokering mechanism Focal points and Network 
5-10 feasibility studies 1 (?) 
Bioindustrial R&D fund No 
6-10 collaborative ventures 8 
10 executive seminars 3 
ci 
The variations between the planned and real out-puts is not necessarily negative. 
It reflects a high degree of flexibility in the execution, which permitted to overcome 
shortcomings in the original planning and the concentration on the more demanded and 
feasible propositions. 
Co-funding 
One important indicator of success of the project, as explicitly acknowledged in 
the project document, is the generation of institutional commitment in the participating 
countries, which can be measured by the co-sponsorship of project activities. The co- 
funding generated by CarnBiotec activities in each country is presented in Table 3. 
Table 3 
Co-funding generated by CamBioTec activities (CAD) 
In-kind Cash Total 
Argentina 105000 20720 125720 
Canada 409000 12000 421000 
Chile ? 
Colombia 70000 70000 
Mexico ? ? 
Total 514000 102720 616720 
The project generated a total co-funding of, at least, CAD 616720, 83 % of it in 
kind (value of the time dedicated by the coordinator and other key persons, travel costs, 
physical facilities, publishing, promotion costs, secretarial support, etc..) and 17 % in 
cash. This represents 61 % of the JDRC contribution, which is considered a significant 
amount. 
This co-funding was generated through co-sponsoring of activities by other 
organizations or agencies and as matching funds, in kind put-up by the host organization 
of the focal points. No attempt was made to generated revenues to cover the costs of 
some activities, as originally planned. 
Relations with other biotech programs 
CamBioTec is only one of several regional or global biotechnology promotion or 
coordination initiatives. The collaboration between them is a crucial factor of their 
success, as it permits the amplification of limited capacities and a more effective use of 
limited resources. The following are examples of these collaborative activities: 
iO 
- Joint seminar on planning, priorities and policies in agricultural biotechnology with the 
Intermediary Biotechnology Service (IBS) of the International Service for National 
Agricultural Research (ISNAR), The Netherlands. 
- Joint meeting with the Biotechnology Policies network of the CYTED, an 
Iberoamerican cooperation initiative. 
- Organization of workshops within REDBIO, which is the periodic plant biotechnology 
congress in Latin America, supported by FAO. 
-Organization of brokering meetings within different technical and commercial 
congresses. 
This policy of CamBioTec and its results is considered very positive. As a 
consequence, CamBioTec is viewed as a valuable partner by other international agencies 
and research centers. 
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Organization 
The organization of CamBioTec is based on focal points in each participating 
country and a general coordination, in the hands of Jose Luis Solleiro. The focal points 
are essentially a coordinator, some technical and administrative support by some 
host institution. Coordinators and support personnel have a high level of personal 
commitment to the CamBiotec initiative, which has been a crucial factor in its 
performance and success. CamBioTec is, in this sense, basically a network of committed 
individuals. The exception to this is the Canadian focal point which, in addition to a 
committed coordinator, has a clear and effective institutional support by BioteCanada. 
The network functions quite informally as it lacks a clear government and 
management structure. The general coordinator as well as the focal point coordinators 
have a high level of discretionary power. The annual work-plans have been discussed in 
coordination meetings held as adjuncts of other gatherings. 
Each focal point presents particular characteristics reflecting local circumstances 
and realities, as shown in Table 4. The most important elements in the effectiveness of 
the focal points are its institutional basis and the dedication by coordinator and other 
technical personnel. 
Table 4 
Organization of CamBioTec focal points 
Argentina Canada Chile Colombia Mexico 
instit. Biotech Biotech Acad. Private Acad. 
association association 
Coordinator Part time Full time Part time Part time Part time 
Assistant Part time No Part time No Part time 
Secretary Full time Shared Shared Shared Shared 
Office Shared Shared Shared Shared 
Advisory Yes No No Yes No 
Committee 
Regionali- No No Yes Yes 
zation 
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The focal points of Argentina and Canada are the most solid as they are based in 
existing biotechnology promotion associations formed by industry and research 
organization. This gives CamBioTec in these countries a high level of legitimacy and 
political leverage. CamBioTec has strengthened significantly these host organizations, 
specially the Foro Argentino de Biotecnologia, giving it a technical capacity and 
dimension which it lacked and needed. 
The focal points in Chile and Colombia are quite weak, as they are based on 
agreements between IDRC and the national science policy organizations, which then 
delegate or subcontract with private or academic organizations. These are not specifically 
biotechnology promotion organizations. The case of Mexico is also quite weak, as the 
focal point responsibility rests with the UNAM, which has no special commitment or 
interest in the project. Recent changes in the policy of the University related to CIT have 
highlighted the risks this situation entails. 
With the exception of Canada, each focal point is a group of mostly three persons, 
generally only dedicated part-time to CamBioTec. This group includes a coordinator, an 
assistant and a secretary. In Mexico it is larger, as the general coordinator is located there 
and other professionals dedicate part of their time to CamBioTec activities, through 
specific contracts. 
Argentina and Colombia have created advisory committees integrated by 
biotechnology leaders from research, government and industry. In the case of Argentina it 
is very active, practically providing governance and steering to the project. It has been an 
important factor in the legitimacy and prestige on the project in this country. 
Mexico and Colombia have regionalized the project to some extent, signing 
agreements with interested organizations in other cities. So an regional focal point exists 
in Chihuahua and in Cali. In the case of Chihuahua, a highly motivated group has taken 
up the CamBioTec concept, and developed an effective workplan with autonomy. In the 
case of Cali, collaborative activities between the focal point and the regional origination 
have been carried out. This strategy has to be viewed with care as it could dilute the 
focus and image of CaniBioTec in the countries as well as increase the complexity of 
managing the project. 
Effective communications between focal points are crucial for the operation of 
the network. It has not been easy to link them electronically, but now they are. 
Remaining difficulties are consequence of operative problems in some focal points. 
The informality of the organization of focal points and the network has been an 
important reason in the success to date, as it permitted the incorporation of highly 
motivated individuals and a high degree of flexibility. But this informality cannot be 
maintained forever, if the permanence and institutionalization of the network is sought. 
Impacts of CamBioTec 
The impact of any research, promotion and coordination program like 
CamBioTec depends on the type of activities, that is, on the concept and the strategy of 
the program, on the size or scale of the program and on the performance or effectiveness 
of its executing agents, in this case, the focal points. Using a combination of indicators 
(use of CamBioTec generated information or decisions in official documents and 
positions, number of partnerships brokered, number of participants in CamBioTec 
organized meetings) and the opinion gathered in the interviews, the impact of 
CamBioTec in the participating countries has been assessed. The results are presented in 
Table 5. 
Table 5: Impacts of CamBioTec in countries 
Planning Policy Information Partnering Applic. 
Argentina High High Good High No 
Canada - - High High No 
Chile - Good Good Good No 
Colombia Good Low Low Good No 
Low Good High High Yes 
Scale used: High-Good-Low 
- = not applicable 
The best impacts have been in the partnering activities, although 
they are limited to the participating companies. This activity has a differential impact on 
biotechnology industry development depending on the size of the industiy. In Canada, for 
example, only a small percentage of companies have shown interest in cooperative 
activities with Latin America, but this percentage is much larger in Latin American 
couniries given the small number of the local biotech industries. So a high percentage of 
the Latin American biotechnology industry has been exposed to Canadian opportunities 
and many of the leading biotechnology companies in the participating countries have 
taken advantage of them. Examples include Biosidus in Argentina, BiosChile in Chile, 
Meristemos in Colombia and Biogenetica, IASA and PROQUISA in Mexico. 
The partnering activities have had a high impact also from the perspective of 
Canadian-Latin American relations. Although CamBioTec build on previous efforts to 
improve them, it has been quite successful in building a channel of communications and 
relations between Canada and Latin American biotechnology industry, strongly helped by 
the more general Canadian interest in the region. 
The provision of basic information on the local biotech scene has had also a very 
good impact, followed by the biosafety and planning activities. CamBioTec (or its focal 
point institutions) is recognized as a valuable source of information in most countries. 
Support to public policy in biotechnology has had a good impact in the case of biosafety 
oversight in Argentina and Chile and the definition of a national policy for access to 
genetic resources in Mexico. The priority setting exercises have had a high direct impact 
only in Argentina were the CamBioTec contribution is explicitly acknowledged in the 
national biotechnology plan. But these exercises have had also indirect impacts,. 
particularly in Mexico, as they have been a crucial element in the progressive 
crystallization of a shared vision of key actors of the role of biotechnology in 
development. 
The promotion of specific applications of biotechnology was only done in 
Mexico, were a strategy for the local manufacture of Bacillus-thuringensis-based 
biopesticides was pursued, with potentially high impacts. 
From a country perspective, the best impacts and influence of the project has been 
in Argentina, because of a very good relationship with policymaking bodies, a solid 
institutional basis and a balance workprogram. The impacts in Mexico have been good, 
reflecting the prestige and respect won by the focal point institution in many years of 
activities. The impacts and influence of the project in Canada are smaller, since its 
activities are only a small part of a large program of biotechnology promotion and 
coordination. The short time the project has been operative in Chile has limited its 
impact. In Colombia, the reason of the relatively smaller impact of the project has been 
the performance of the focal point. 
In Argentina, Canada and Mexico many interviewed persons did not clearly 
perceive the difference or identity of CamBioTec against its focal point institutions. So 
many identified the Foro Argentino de Biotecnologia, the CIB and the CIT as responsible 
for CamBioTec activities, which is positive. In general, CamBioTec has a very good 
image in the countries, as a effective and well organized program. 
In conclusion, the general impact of CamBiotec is judged very good, given the 
relatively small scale of the program, compared with the size and difficulty of the 
addressed problem, which is the development of biotechnology in the region. 
'S 
Conclusions on CamBioTec 
The balance of first phase of CamBioTec can by summarized as follows: 
Strength 
- Functioning focal points and network 
- Basic information on national biotechnology 
- Good image in most countries 
- Work on biosafety 
- Partnering activities 
- Relations with Canada 
- Institutional basis in some countries 
- Certain dispersion of activities/lack of focus 
- Socio-economic research and promotion of direct applications of biotechnology 
- Lack of sustainable development activities 
- Lack of activities to enhance public awareness of importance of biotechnology 
- Information on CamBioTec/Relations with media 
- Programming and follow-up 
Opportunities 
- Need for national biotechnology "champion" 
- Broaden political base of focal points through incorporation of important actors 
- Interest in helping countries in awareness of new trends in biotechnology 
- Exploit synergies of net-work 
- Need in countries of capabilities to articulate and negotiate projects 
- Increasing importance of environmental issues 
- Continuing importance of free trade in hemisphere 
Threats 
- High dependence on coordinators in some countries 
- Difficulties of institutionalization of network 
- Lack of interest by key actors 
- Perception of "too Canadian" 
- Competition of other similar initiatives (nationally and regionally) 
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In summary, CamBiolec has developed into a successful network of persons, 
with good capabilities to promote biotechnology through support to policy design and 
management, as well as brokering of joint ventures between companies and 
governmental agencies, which has had a significant impact in its short lifetime. It has 
been less successful till now to promote research into the socio-econornics of 
biotechnology and in promoting direct applications of biotechnologies. 
Issues in CamBioTec's future 
What should CamBioTec's mission be'? 
CamBioTec was designed as an ambitious mechanism to promote and foster 
biotechnology in some Latin American countries through planning activities, socio- 
economic research, support to policy design and management, negotiation of direct 
applications of biotechnologies, and helping in the transfer of technology from Canada 
to local companies. The experience of three years has shown that some of these activities 
are needed and feasible, and the success of the project has been based on its 
concentration on those. 
The capabilities to plan and execute these more limited set of activities conform a 
specific institutional model, which is a biotechnology promotion organization or, more 
generally, an association of any group of organizations to further some shared interest or 
goals. This group will perhaps need to develop or strengthen a shared vision of its 
common interests; need expand its coverage, that is, spread its vision; lobby or pressure 
other organizations to do something in its interest; and help its members with services of 
interest to all and that do not affect the possible competition between members; and 
towards this, effective associations governed by its members or founders are needed. 
If the institutionalization of CamBioTec is sought, understanding as such the 
transformation of the current project into a self sustained organization and work program, 
capable of existing without financial support from IDRC, this reality has to be built on. 
The successful elements of the CamBioTec project point towards its future. There is a 
need in all CamBioTec countries, excluding Canada, either to strengthen existing 
associations like the Foro Argentino de Biotecnologia, or to create biotechnology 
promotion organizations. CamBioTec already is a national reference on biotechnology 
information and advice in these countries, making this step feasible. In this way, the 
"national biotechnology champions" envisioned in the project document could become a 
permanent reality. 
The focus of these associations will be first of all providing basic services to its 
members and to a broader clientele. Since its members have to be principally the 
biotechnology industry, as the most directly interested parties in the development of 
biotechnology, these services have to be necessarily in the area of commercial 
biotechnology, that is, information on industry, regulatory and legal requisites, 
opportunities, etc., brokering services and lobbying capacities to influence the 
development of a favorable environment for biotechnology. Once these basic services are 
in place, other services or activities, not so directly related to the biotechnology industry, 
can be pursued like, for example, fomenting research into socio-economic aspects of 
biotechnology. 
The mission of the envisioned biotechnology promotion associations, in the long 
run, will depend on who governs them. If these organizations are created exclusively as 
industry associations its mission will be restricted to promoting more limited industry 
interests. Its is highly recommended that other organizations interested in biotechnology 
participate in the creation of these type of organizations which will permit a broader 
national development oriented mission, as is the case with BioteCanada and Foro 
Argentino de Biotecnologia, in which industry teams up with research centers and 
government agencies. 
The preceding analysis has several important implications. One is that, in the long 
run, CamBioTec probably will loose its Canadian orientation, to be substituted by a more 
general one of linking similar organizations in the Americas or even globally. Another 
one is that such organizations and network will have a own dynamic, which will be 
different from IDRC policies and objectives. This does not mean that it will be still very 
useful for IDRC purposes. 
Role of research vs. other activities 
The role of research in the kind of organizations and network CamBioTec is 
evolving into, is clearly secondary. This means that IDRC will have to establish a special 
and explicit way of maintaining a research component in a possible second stage of the 
project, to guaranty that its activities conform closer to IIDRC's central mandate. 
Feasibility of creation of biotechnology promotion associations 
If it is true that CamBioTec is evolving towards a network of national 
biotechnology promotion associations, the feasibility of creating these type of 
organizations in the current CamBioTec countries or in others is crucial in the future of 
the project. The basic condition for these creations would be the interest and willingness 
of leading companies, research institutes and governmental agencies to associate with 
these purposes. Based on the opinions gathered in the interviews done, it is judged in the 
following way: 
Chile: Important Chilean institutions like the Sociedad Nacional de Agricultura, 
the Fundacion Chile and key companies, like BiosChile, have recently been 
sensibilized to the need and possibilities of creating a special biotechnology 
promotion organization, very similar conceptually to CamBioTec, by Pablo 
Valenzuela, an influential businessman and researcher. This project is too 
ambitious and costly and is now stalled, but it opens the way for a more modest 
and practical proposal by CamBioTec. The feasibility of creating such an 
organization in Chile is judged therefore high. 
Mexico: There is an explicit interest by ASEMBI , a dormant biotechnology 
industry association, to team up with CamBioTec as a way of reactivating this 
association. This would also be of interest to other influential companies and 
organizations. It seems highly feasible to create a special organization to 
capitalize the CamBioTec prestige, with a broader political base and therefore 
legitimacy than the UNAM. 
Colombia: The situation in Colombia is complicated by the existence of three 
biotechnology promotion organizations, stimulated and supported by the 
government, with theoretically very similar objectives as CamBioTec. These 
organizations are still in a consolidation phase, but have to be taken into account 
in any strategy for the institutionalization of CamBioTec in this country. 
Financing of CamBioTec 
A crucial issue in the future of CamBioTec is the possibility of generating 
alternative sources of financial support or revenues to the current dependence on the 
IDRC grant. As the experience of the project shows, it is relatively easy to generate co- 
funding for specific activities. The problems lies in the financing of the basic costs of the 
focal points and of the network, as most agerccies have limitations to cover core 
personnel and administrative costs. 
There are at least three ways of solving this problem. If the focal point is an 
association of several organizations, membership contributions or fees can normally 
cover its basic costs. Secondly, these associations could also secure special generic 
contributions by governmental agencies, specially for good work programs, at least for 
some consolidation period. Thirdly, a cost recovery strategy can generate resources for 
covering the basic cost of the organization, if the concept of overheads is used. 
Since the basic costs of a focal point are rather modest, it should be possible to 
generate the needed funds by a combination of these strategies. Nevertheless, the focal 
points need some time for developing these strategies and their corresponding skills. 
Therefore, a limited support by IDRC for a short period is crucial to pennit these 
adjustments and learnings. 
Expansion and broadening of the network 
Many of the interview persons brought up the questions of the expansion of the 
network to other countries and of broadening the focus of activities from the agricultural, 
agroindustrial and environment sectors included now to all impacted by biotechnology 
and particularly human health. Interest to include Brazil and to solve the problems faced 
in Cuba is great. 
An attempt to create a focal point in Brazil failed. This country has a 
biotechnology industry association, ABRABI, which apparently has been recently 
reactivated. This opens a new opportunity to incorporate Brazil into CamBioTec, which 
is judged very important by other members of the network. Other institutional 
alternatives could be explored also to this end. In a similar way, there are several 
alternatives of focal point institutions in Cuba which could overcome the current 
problems faced in this countr. 
The issue of broadening the focus of CamBioTec must be discussed in relation to 
specific activities. Actually, current brokering and information activities do not exclude 
any sector. But the maintenance of the current, more limited focus in research and policy 
activities is considered convenient, so to concentrate limited resources. 
As concluded before, the informal organization of CamBioTec has until now 
being very useful in the search of an adequate concept and mission. But the 
institutionalization of CamBioTec, and particularly the development of an independent 
financial basis, requires a more formal organization. The crucial issue in it will be the 
governance of the focal pointsand of the network. 
If the focal points will be basically associations of interested parties it is straight 
forward that its governance should be in the hands of its member organizations, probably 
through a board and a general assembly of members. The network would be an 
association of national focal point institutions, and therefore its governance should be 
these institutions. They could meet periodically to this end or delegate in a board 
designated by them. 
The experience in Latin America and elsewhere shows that it is very difficult of 
maintaining functioning regional organizations of the kind proposed above, because of 
the involved costs. This will depend very much on the interest of the national 
organizations and on the effective use of all opportunities offered by modern 
communication technologies to overcome theses costs. 
For a transition period, covered by a possible second phase of the IDRC support, 
an ad-hoc steering committee, board or advisory committee could take up the governance 
of the network. 
Proposal on the future of CamBioTec 
The success of CamBioTec in the more direct promotion of biotechnology, as 
presented above, shows that currently there is a need for such type of organizations in the 
Americas. This need will conceivable be more important in the future because of the 
increasing importance of economic and environmental issues that by definition are 
hemispheric or global and therefore need effective multinational coordination and 
communication structures, which currently exist only in a limited way. A structure like 
the one build up by CarnBioTec offers great opportunities to further free trade goals, one 
the one hand, and address environmental problems and opportunities on the other. 
Vision and mission 
In such a favorable regional context, the following vision of CamBiotec is proposed: 
Network of small, agile, effective and highly regarded organizations, which are 
the best informed on national biotech scene, promoting the rapid and efficient 
incorporation of biotechnologies into national or regional social and economic 
development strategies 
The focal points or its supporting institutions should have the following missions: 
- Promotion of biotechnology in country 
- Support the development of a favorable legal, regulatory, financial and science 
policy climate for biotechnology 
- Promote the transfer of adequate biotechnologies 
Objectives of a second phase 
Given the success of CamBioTec, its current dependence of the IDRC support 
and its great potential in the future if it institutionalizes adequately, a second phase of 
IIDRC support, designed to help in the transition towards an institutionalized and self- 
supporting network of national associations is essential. In this respect, a second phase 
of an IDRC supported CamBioTec project, should have the following objectives: 
1. Institutionalize focal points where needed 
- In the case of Argentina integrate CamBioTec closer into the Foro Argentino de 
Biotecnologia, turning it into the technical direction of it. 
- In Chile, Colombia and Mexico new organizations, with participation of industry and 
research organizations, should be created to carry on with the CamBioTec program of 
work. 
- Define a policy for auto-financing the focal points 
2. Consolidate and expand net-work 
- Formalize a structure and governing body for the network 
- Support technically creation of focal points in Brazil and Venezuela 
- Create website for CamiBioTec linking national websites 
3. Strengthen basic service capabilities of focal-points 
- Systematize and improve the quality of information on national biotech like: 
Directories 
Compendia of regulations, laws, financing opportunities 
Documentary data bases 
- Develop skills in brokering of partnerships 
- Systematize relations with media to inform on CamBioTec 
- Create virtual network of experts in biotechnologies 
4. Develop capabilities to negotiate cooperative projects 
- Create seed-money flmd for design and negotiation of cooperative projects in priority 
thematic areas for the development of biotechnology in the countries. These funds 
would permit finance the design and negotiation costs, as well as provide some 
limited matching funds for the project as such. 
- Selected areas will depend on IDRC, national and other agency interest in each 
country or in the region. Examples are the following: 
Socio-economic impact studies 
Public awareness/attitudes on biotechnology 
Harmonization of regulations 
Strengthening of institutional capabilities for overview of biotech 
Sectorial analysis of biotech opportunities 
Policy issues in biodiversity use and conservation 
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ANNEX 1: LIST OF INTER VIE WED PERSONS 
Argentina 
Industry 
Dra. Vatentina Carricarte, Chief, Biotechnology Department, GADOR S.A. and Secretary 
General of Foro Argentino de Biotecnologia. 
Dr. Juan Carlos Repetto, General Manager. Laboratorios BIOTAY S.A. 
Dr. Marcello Criscuolo, Executive Director, BlO SIDUS S.A. 
Mr. Jorge Gianbiaggi, President, Sintesis Quimica SAIC 
Ms. Maria Marta McCarthy, Manager, Foro Argentino de Biotecnologia 
Government 
Ing. Carmen Vicien, Director of Agricultural Production, Secretaria de Agricultufa, 
Ganaderia y Pesca 
Ing. Perla Godoy, Tecnical Secretary of CONABIA 
Research 
Dr. Eduardo Charreau, Director of Instituto de Biologia y Medicina Experimental, 
CONICET 
Dr. Eduardo Palma, Coordinator, Advanced Biotechnology Program, INTA 
Dr. Eduardo Trigo, Executive Director, Fundacion Argenlnta 
CamBioTec 
Drs. Juan Dellacha and Juan Carlos Carullo 
Canada 
Industry 
Dr. Peter McCann, President, Ag-West Biotech 
Mr. John Cross, President, Philom Bios 
Ms. Joyce Groot, President, BlOTECanada 
Mr. Rick Walters, Vice-President, BIOTECanada 
Dr. Paul Kolodziejczyk, Head, POS Corp. 
Government 
Dr. John Jaworski, Senior Industry Development Officer, Industry Canada 
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Dr. Terry Mcintyre, Head, Biotechnology Advancement Program, Environment Canada 
Ms. Margaret Kenny, Associate Director, Biotechnology Coordination Office, 
Agriculture and Agri-Food Canada 
Mr. Bernard Badani. Deputy Director, Grain & Oilseeds Division, AAFC 
Dr. Paul Mayers, Head. Office of Food Biotechnology, Health Canada 
Ms. Karen McIntyre, Office of Food Biotechnology, Health Canada 
Ms. Andre Potvin, CIDA 
Research 
Dr. Charles Davis, University of New Brunswick 
CamBioTec and IDRC 
Dr. Bill Edwardson, JDRC 
Dr. Brent Herbert-Copley, IDRC 
Mr. Carlos Yuste, IDRC 
Dr. Scott Tiffin, JDRC 
Dr. Javier Verastegui, CamBioTec 
Chile 
Industry 
Dr. Arturo Yudelevich, Vive-President, BIOS CHILE 
Dr. Eduardo Bitran, General Manager, Fundacion Chile 
Ms. Lidia Vidal, Manager, Marine Resources, Fundacion Chile 
Dr. Pablo Valenzuela, President, BIOS CHILE 
Ms. Loreto Gardeweg, Manager, Laboratorios Linsan 
Mr. Manuel Bacigalupo, General Manager, Semillas SNA 
Government 
Dr. Ramiro Trucco, Director of Regional Cooperation, C1DA 
Dr. Mauricio Sarrazin, President, CONICYT 
Ms. Ximeria Gomez, Director, International Relations, CONICYT 
Mr. Eduardo Santibañez, FONDEF 
Mr. Christian Gonzalez, FONTEC 
Dr. Carlos Pifia, Coordinator, International Relations, CONAMA 
Ing. Carmen Cabrera, Chief of Department, SAG 
Research 
Dr. Carlos Mufloz, General Director, INIA 
Dr. Juan Izquierdo, Coordinator REDBIO, FAO 
CamBioTec 
Dr. Lionel Gil and Mr. Carlos Irarrazabal 
Colombia 
Industry 
Dra. Miriam Sanchez, Director, Corporacion BIOTEC 
Mr. Francisco Ramirez, Manager, Productos VITA 
Mr. Mauricio Lieras, General Director, MERISTEMOS 
Dr. Francisco Palacios, Manager R&D, Coltabacos 
Dr. Gabriel Cadena, Director, CENICAFE 
Dra. Elizabeth Hodson, Chief, National Biotechnology Program, Colciencias 
Dr. Jorge Ahumada, General Director, Colciencias 
Research 
Dr. Gustavo Buitrago, Director, Instituto de Biotecnologia, Universidad Nacional 
Dr. Luis Alejandro Barrera, Director of Postgraduate Studies, Universidad Javeriana 
Dr. Andres Laignelet, Manager, Plant Biotechnology Program, CorpolCA 
CamBioTec 
Dra. Marta Emilia Rueda 
Mexico 
Industiy 
Dr. Alejandro Gallegos, President, Biogenetica Mexicana 
Ing. Alejandro Romero, General Director, JASA 
Ing. Luis Medina. General Director, PROQUISA 
Government 
Dr. Eduardo Benitez, Director, Seed Department, SAGAR 
Dr. Jaime Martuscelli, Director Adj unto, CONACYT 
IDRC / CR01 
111111 Hill 11111 HIl 1111111111 Ill 
294092 
Ing. Marco Antonio Cotero, Subdirector Plant Health, SAGAR 
Dr. Victor Villalobos, Subsecretario, SEMARNAP 
Research 
Dra. Suzanna Aspiroz, Chief of Biotechnology Laboratory, INIFAP 
Dr. Jorge Kondo, Executive Director, INIFAP 
Dr. Rodolfo Quintero. UNAM 
CamBi oTec 
Ms. Rosario Castafion and Dr. Jose Luis Solleiro 
